Montelukast Tablet
Product Images NDC 33342-102

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 33342-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Montelukast 30s

This is a description of a medication called Montelukast Sodium Tablets in 10mg strength for adults aged 15 years and older. The packaging suggests that patients should consult the included Patient Information Leaflet before use, and it also provides information on where it should be stored. The medication was manufactured for Macleods Pharma USA, Inc. in Plainsboro, NJ, and was made by Macleods Pharmaceuticals Ltd in Baddi, Himachal Pradesh, India.*

FDA Label Image

Montelukast 500s

ACLEODS Montelukast sodium, USP 10.4 mg film-coated tablets are equivalent to Montelukast 10 mg, used for adults aged 15 years or older. The tablets should be stored at 20° to 25°C, with excursions up to 15° to 30°C permitted. The product container should be subdivided, repackaged into a well-closed, light-resistant container with the attached patient information leaflet. The tablets are manufactured for Macleods Pharma USA, Inc. by Macleods Pharmaceuticals Ltd. The code no. is HP/152/07.*

FDA Label Image

Montelukast 90s

This is a description for Montelukast Sodium Tablets with 10 mg strength, which is intended for adults aged 15 years and older. The tablets contain Montelukast sodium, USP 10.4 mg, equivalent to Montelukast 10 mg. The usual dosage is defined in the prescribing information. The tablets are to be stored at 20° to 25°C (68° to 77°F) with permitted excursions to 15° to 30°C (59° to 86°F). The product is manufactured by Macleods Pharmaceuticals Ltd. in India and distributed by Macleods Pharma USA, Inc. in Plainsboro, NJ 08536. Pharmacies dispense the product with an attached patient information leaflet.*

FDA Label Image

Montelukast-fig-1 (Montelukast Fig 1)

The text appears to be a table showing the mean percent change from baseline for a treatment over a period of 15 weeks, with a washout period included. The two treatments listed are Placebo and Montelukast Sodium. The table includes a visual representation with a vertical line to indicate the start and end of the treatment period, and horizontal lines to represent the changes in percentage.*

FDA Label Image

Montelukast-structural (Montelukast Structural)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.